ArticleJournal of the National Cancer Institute2025

Correction to: FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.